Bid now to compete with your favorite celebrities at Labyrinth Theater Company's Annual Celebrity Charades event on Oct. 27 in NYC. This auction package allows you to sit with celebrity participants backstage, compete onstage and enjoy VIP cocktails, dinner and after party.
On October 27th, Labyrinth Theater Company will host its annual signature fundraising event: Celebrity Charades, a thrilling and hilarious competition where teams of celebrities go head-to-head in a game of speed charades.
You and a guest will receive VIP tickets to Celebrity Charades, at Capitale in NYC, which include a VIP cocktail hour, priority seating at dinner, and access to an exclusive after party. And during dinner you will be invited onstage to join one of four teams of celebrities facing-off in a game of speed charades. In-between rounds you get to rub elbows and sip cocktails in the backstage celebrity lounge area.
The following celebrities are confirmed to play this year:
Past Players Include:
Rose Byrne, Bobby Cannavale, Sasha Cohen, Tom Colicchio, Billy Crudup, Alan Cumming, Mos Def, Peter Dinklage, Edie Falco, America Ferrera, Ethan Hawke, Mariska Hargitay, Woody Harrelson, Philip Seymour Hoffman, Taran Killam, Richard Kind, John Krasinski, Padma Lakshmi, Juliette Lewis, Justin Long, Julianna Margulies, Christopher Meloni, Bebe Neuwirth, Ed Norton, Amanda Peet, Rosie Perez, Amy Poehler, Julia Roberts, Chris Rock, Sam Rockwell, Paul Rudd, Maya Rudolph, Taylor Schilling, Amy Sedaris, Amanda Seyfried, Michael Shannon, Justin Theroux, Kristen Wiig, Robin Williams, Elijah Wood, Evan Rachel Wood and so many more.
The evening will unfold as follows:
Labyrinth Theater Company is an artistic home for diverse theater artists and the daring and visceral work they create. Led by Artistic Director Mimi O’Donnell and Executive Director Danny Feldman, Labyrinth produces an annual season of three new plays at their West Villlage theater.
Notice of Updated Buyer Terms of Use
We have recently updated our Buyer Terms of Use. We encourage you to review the revised terms to ensure continued understanding and compliance. By continuing to use our platform, you acknowledge and agree to the updated terms. View the updated Terms of Use